Katsunori Masaki
Overview
Explore the profile of Katsunori Masaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
690
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tagaya E, Shinada J, Nagase H, Terada-Hirashima J, Hojo M, Sugihara N, et al.
J Asthma
. 2025 Jan;
:1-11.
PMID: 39874464
Background: Persistent cough bothers many patients with asthma because it worsens their quality of life; therefore, it must be remedied immediately. The efficacy of triple therapy as a first-line treatment...
2.
Nagase H, Kobayashi K, Toma-Hirano M, Suzukawa M, Harada N, Masaki K, et al.
Allergol Int
. 2025 Jan;
PMID: 39848869
Background: Although randomized controlled trials (RCT) have demonstrated the efficacy of mepolizumab for asthma, they have excluded certain patient subgroups. To bridge the gap between RCT and real-world practice, the...
3.
Watase M, Shiraishi Y, Chubachi S, Tanabe N, Maetani T, Asakura T, et al.
Circ J
. 2025 Jan;
89(3):373-381.
PMID: 39828330
Background: Coronary artery calcification (CAC) detected through chest computed tomography (CT) strongly predicts cardiovascular events in asymptomatic individuals undergoing primary prevention. Few studies with limited sample sizes have investigated the...
4.
Shirai T, Hirai K, Akamatsu T, Mizumura K, Sasano H, Harada N, et al.
Allergol Int
. 2025 Jan;
PMID: 39809630
No abstract available.
5.
Adachi T, Narimatsu N, Ogawa Y, Toriya M, Fukushi T, Shirabe M, et al.
World Allergy Organ J
. 2025 Jan;
18(1):101004.
PMID: 39758937
Background: This study examined the relationship between the disciplinary diversity of research teams and research output (RO) in allergy and immunology programs funded by the National Institutes of Health (NIH)...
6.
Takaoka H, Kawada I, Hiruma G, Nagashima K, Terai H, Ishida N, et al.
BMJ Open Respir Res
. 2024 Dec;
11(1.
PMID: 39721744
Objectives: Severe acute respiratory syndrome coronavirus 2 significantly impacts Japan with a high number of infections and deaths reported. Long coronavirus disease (COVID) characterised by persistent symptoms after COVID-19 has...
7.
Konishi S, Masaki K, Shimamoto K, Ibuka Y, Goto R, Namkoong H, et al.
IJID Reg
. 2024 Dec;
14:100495.
PMID: 39717862
Objectives: We examined shifts in labor productivity and their economic ramifications among adult patients with long COVID in Japan. Methods: A total of 396 patients were categorized into three groups...
8.
Watase M, Masaki K, Chubachi S, Namkoong H, Tanaka H, Lee H, et al.
Int J Infect Dis
. 2024 Dec;
151:107322.
PMID: 39662225
No abstract available.
9.
Masaki K, Suzukawa M, Sasano H, Harada N, Miyazaki Y, Katsura H, et al.
Allergol Int
. 2024 Dec;
PMID: 39632158
Background: Biologics are integral in the management of severe asthma. As the effectiveness of the anti-IL-5 receptor antibody benralizumab in Japan remains elusive, this study aimed to assess its real-world...
10.
Sunata K, Miyata J, Kawashima Y, Konno R, Ishikawa M, Hasegawa Y, et al.
Front Immunol
. 2024 Oct;
15:1445769.
PMID: 39439801
Introduction: Elevated blood eosinophil levels in patients with chronic obstructive pulmonary disease (COPD) with or without asthma are linked to increased exacerbations and the effectiveness of inhaled corticosteroid treatment. This...